America’s 100 percent tariff on patented drug imports is now live for the industry’s biggest importers, and the first full business week under the new regime is testing supply chains, pricing models and Washington’s onshoring bet all at once. WASHINGTON, Aug. 3, 2026 – The most aggressive pharmaceutical trade action in modern American history is…
A two year countdown on generic drug tariffs formally began Saturday, giving the manufacturers of nine in ten American prescriptions until August 2028 to build in the United States or face duties of 100 percent, then 200 percent. WASHINGTON, Aug. 2, 2026. The most consequential tariff of the week is one that, for now, collects…
Six days before 100 percent tariffs hit patented medicines, three of the world’s biggest drugmakers still have no onshoring deal, generic makers have a new 200 percent deadline of their own, and the US drug supply chain is bracing for the most expensive week in its history WASHINGTON, July 25, 2026 The most consequential tariff…